Osteopathic Family Physician
Volume 2, Issue 2 , Pages 41-45 , March 2010

Risk factors for addiction

  • Steven W. Clay, DO

      Affiliations

    • Corresponding Author InformationCorresponding author: Steven W. Clay, DO, Associate Professor, Ohio University College of Osteopathic Medicine, Athens, OH 45701

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Arlington, VA: Author; 2000;
  2. American Medical Association. Balancing the response to prescription drug abuse: report of a national symposium on medicine and public policy. In: 1990;p. 1–6
  3. DeWit DJ, Offord DR, Wong M. Patterns of onset and cessation of drug use over the early part of the life course. Health Educ Behav. 1997;24:746–758
  4. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psych Bull. 1992;112:64–105
  5. Fowler T, Lifford K, Shelton K, et al. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction. 2007;102:413–422
  6. Vaillant GE. Natural history of addiction and pathways to recovery. In:  Graham AW,  Schultz TK,  Mayo-Smith MF,  Ries RK,  Wilford BB editor. Principles of Addiction Medicine. 3rd ed.. Chevy Chase, MD: American Society of Addiction Medicine; 2003;p. 3–16
  7. Oxford ML, Harachi TW, Catalano RF, et al. Preadolescent predictors of substance initiation: a test of both the direct and mediated effect of family social control factors on deviant peer associations and substance initiation. Am J Drug Alcohol Abuse. 2001;27:599–616
  8. Dube SR, Felitti VJ, Dong M, et al. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111:564–572
  9. Bulik CM, Prescott CA, Kendler KS. Features of childhood sexual abuse and the development of psychiatric and substance use disorders. Br J Psychiatry. 2001;179:444–449
  10. Snyder LB, Milici FF, Slater M, et al. Effects of alcohol advertising exposure on drinking among youth. Arch Pediatr Adolesc Med. 2006;160:18–24
  11. Manning WG, Blumberg L, Moulton LH. The demand for alcohol: the differential response to price. J Health Econ. 1995;14:123–148
  12. Jonas S. The public health approach to the prevention of substance abuse. In:  Lowinson JH editors. Substance Abuse, A Comprehensive Textbook. 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 1255–1267
  13. Winstanley EL, Steinwachs DM, Ensminger ME, et al. The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend. 2008;92:173–182
  14. Hayatbakhsh MR, Mamun AA, Najman JM, et al. Early childhood predictors of early substance use and substance use disorders: prospective study. Aust N Z J Psychiatry. 2008;42:720–731
  15. Horner BR, Scheibe KE. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997;36:30–36
  16. Gordon SM, Tulak F, Troncale J. Prevalence and characteristics of adolescent patients with co-occurring ADHD and substance dependence. J Addict Dis. 2004;23:31–40
  17. Gau SS, Chong MY, Yang P, et al. Psychiatric and psychosocial predictors of substance use disorders among adolescents: longitudinal study. Br J Psychiatry. 2007;190:42–48
  18. Ferdinand RF, Blum M, Verhulst FC. Psychopathology in adolescence predicts substance use in young adulthood. Addiction. 2001;96:861–870
  19. Doherty EE, Green KM, Ensminger ME. Investigating the long-term influence of adolescent delinquency on drug use initiation. Drug Alcohol Depend. 2008;93:72–84
  20. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev. 2006;30:215–238
  21. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol. 1998;12:54–67
  22. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet. 2005;6:521–532
  23. Connor JP, Young RM, Lawford BR, et al. D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. Eur Psychiatry. 2002;17:17–23
  24. Saxon AJ, Oreskovich MR, Brkanac Z. Genetic determinants of addiction to opioids and cocaine. Harv Rev Psychiatry. 2005;13:218–232
  25. Noble EP, Gottschalk LA, Fallon JH, et al. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet. 1997;74:162–166
  26. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325–341
  27. Kendler KS, Prescott CA, Myers J, et al. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937
  28. De Bellis MD. Developmental traumatology: a contributory mechanism for alcohol and substance use disorders. Psychoneuroendocrinology. 2002;27:155–170
  29. Groman SM, James AS, Jentsch JD. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2009;33:690–698

PII: S1877-573X(09)00141-5

doi: 10.1016/j.osfp.2009.12.002

Osteopathic Family Physician
Volume 2, Issue 2 , Pages 41-45 , March 2010

Article Tools